Heart failure hope: weight loss drug trial targets obese patients
NCT ID NCT05371496
Summary
This study is testing if a medication called semaglutide, which is used for weight loss, can improve heart function and symptoms in obese patients with a specific type of heart failure. Researchers will give the drug or a placebo to 81 participants to see if aggressive weight loss helps the heart work better during exercise. The main goal is to see if it lowers pressure in the heart's blood vessels when patients are active.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.